Magazine Article | May 9, 2017

Journey To The Corporate Boardroom

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

PART 3: CURIOUS WHAT SERVING ON A CORPORATE BOARD ENTAILS?

If you have never served on a corporate board, you might be curious as to what it all entails. Thanks to BioBreak and Drexel University, Life Science Leader undertook the development of a threepart series of articles titled “Journey To The Corporate Boardroom.” Part 1 explored how to seek a board opportunity, while Part 2 dug into what leaders should be thinking about when building their company boards. In this final installment, we delve into what serving on a corporate board is really like. For insights we engaged the following five executives: Richard Baron, former CFO and board member of Zynerba Pharmaceuticals; Rich Daly, president, CEO, and chairman of the board for Neuralstem; Don Hayden, former global pharmaceuticals president for Bristol-Myers Squibb and current board member of several biopharmaceutical companies; Kirk Gorman, former CFO and EVP of Jefferson Health Systems and board member of several companies; and Gwen Melincoff, founder of Gemini Advisors and board member for Kamada Pharmaceuticals and former board member of Tobira Therapeutics.

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.